InvestSMART

Audeara Limited (ASX:AUA)

ALERT: Price-sensitive ASX Announcement for AUA
Current share price for AUA : $0.036 0.006 (20%)+
Release
30 Jul 2026 8:33AM
Price at Release
$0.030
Full Release
download
Summary
Audeara Limited's Q4 FY26 activities report highlighted significant financial and operational developments. The company achieved $709k in customer receipts for the quarter and $4.2m for the year. Their unaudited revenue for Q4 was $0.47m, bringing the full-year total to $4.44m, an increase from FY25. Operating cash outflows were reduced, marking the lowest in company history. Key operational advancements included progressing the Optek AI audio licensing agreement and securing exclusive rights for the Shokz Health Global product. The company initiated a large Auracastâ„¢ rollout and continued to expand its technology programs, focusing on scalable licensing pathways. Cash reserves were at $0.74m at the end of the period.
Key Points
  • Receipts from customers totaled $709k for Q4 FY26, with full-year cash receipts at $4.2m.
  • Unaudited Group revenue for Q4 FY26 was $0.47m, contributing to a full-year unaudited revenue of $4.44m.
  • Net operating cash outflows for Q4 were $795k, totaling $415k for FY26, marking the lowest in Company history.
  • Australian wholesale revenue was $376k for Q4 and $2.6m for FY26, a 46.4% increase from FY25.
  • Cash and cash equivalents stood at $0.74m as of 30 June 2026.
  • Advancement in Optek chip-level AI audio licensing agreement towards commercial production.
  • Exclusive Australian market agreement with Shokz Health Global for the OpenLearn Small solution.
  • Large-scale Auracastâ„¢ rollout across 43 retirement villages initiated.
  • Continued expansion of Auracastâ„¢ programs across multiple sectors.
  • Focus on converting AUA Technology programs into scalable licensing opportunities.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.